IP Verse

Substituted Benzylindazoles For Use As Bub1 Kinase Inhibitors In The Treatment Of Hyperproliferative Diseases. - EP2763982

The patent EP2763982 was granted to Bayer on Jan 10, 2018. The application was originally filed on Oct 4, 2012 under application number EP12766997A. The patent is currently recorded with a legal status of "No Opposition Filed Within Time Limit".

EP2763982

BAYER
Application Number
EP12766997A
Filing Date
Oct 4, 2012
Status
No Opposition Filed Within Time Limit
Nov 16, 2018
Grant Date
Jan 10, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents